Connection

CHOLADDA CURRY to Lymphoma, T-Cell

This is a "connection" page, showing publications CHOLADDA CURRY has written about Lymphoma, T-Cell.
Connection Strength

1.567
  1. A clinicopathologic study of the spectrum of systemic forms of EBV-associated T-cell lymphoproliferative disorders of childhood: A single tertiary care pediatric institution experience in North America. Pediatr Blood Cancer. 2019 08; 66(8):e27798.
    View in: PubMed
    Score: 0.626
  2. Pediatric subcutaneous panniculitis-like T-cell lymphoma with features of hemophagocytic syndrome. Pediatr Blood Cancer. 2013 Nov; 60(11):1916-7.
    View in: PubMed
    Score: 0.418
  3. TrkA is a binding partner of NPM-ALK that promotes the survival of ALK+ T-cell lymphoma. Mol Oncol. 2017 09; 11(9):1189-1207.
    View in: PubMed
    Score: 0.137
  4. SUMOylation Confers Posttranslational Stability on NPM-ALK Oncogenic Protein. Neoplasia. 2015 Sep; 17(9):742-754.
    View in: PubMed
    Score: 0.121
  5. The transcription factors Ik-1 and MZF1 downregulate IGF-IR expression in NPM-ALK? T-cell lymphoma. Mol Cancer. 2015 Feb 25; 14:53.
    View in: PubMed
    Score: 0.117
  6. NPM-ALK up-regulates iNOS expression through a STAT3/microRNA-26a-dependent mechanism. J Pathol. 2013 May; 230(1):82-94.
    View in: PubMed
    Score: 0.102
  7. Haemophagocytic lymphohistiocytosis and Epstein-Barr virus: a complex relationship with diverse origins, expression and outcomes. Br J Haematol. 2022 01; 196(1):31-44.
    View in: PubMed
    Score: 0.045
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.